Jump to content

COVID-19 - April 23: Thailand reports 20,052 new coronavirus cases, 22,361 recoveries, 129 deaths


Recommended Posts

Posted

COV23.jpg

File photo

 

Thailand on Saturday (April 23) reported 20,052 new COVID-19 cases, 22,361 recoveries and 129 additional deaths over the past 24 hours. 

 

Saturday’s cases bring the total number of COVID-19 infections in Thailand to 4,148,090 with 27,649 deaths.

 

The news comes the Center for Covid-19 Situation Administration (CCSA) on Friday, decided to relax disease controls from May 1, ending control (orange) zones in its revision of the colour-coded zoning during Friday’s meeting.

 

Only high surveillance (yellow) zones and tourism pilot (blue) zones will remain, starting from May 1.

 

There will be no more maximum and strict Covid-19 control (dark-red), maximum control (red) zones, surveillance (green) zones.**

 

**Thai News Agency contributed to this report

 

Join our daily ASEAN NOW Thailand Newsletter - Click to subscribe

 

Asean-now_Covid-Dashboard-Stats-Graphic-Template-Thailand-(update23APR).png

 

 

asean_now_BB.jpg

-- © Copyright  ASEAN NOW 2022-04-23

 

- Cigna offers a range of visa-compliant plans that meet the minimum requirement of medical treatment, including COVID-19, up to THB 3m. For more information on all expat health insurance plans click here.

 

 
Get your business in front of millions of customers who read ASEAN NOW with an interest in Thailand every month - email [email protected] for more information
Posted

Phuket marks 149 new COVID cases, no deaths

 

PHUKET: The latest Phuket Provincial Public Health Office (PPHO) daily COVID situation report has marked 149 new local infections confirmed across the island yesterday (Apr 22), bringing the total number of infections recorded since Jan 1 to 51,612.

 

https://www.thephuketnews.com/phuket-marks-149-new-covid-cases-no-deaths-83904.php

Image: PPHO

  • Like 1
Posted

Two-thirds of Covid beds still empty post-Songkran but child cases up

 

“Currently 35.8 per cent of around 180,000 hospital beds for Covid-19 patients are being used,” department director-general Somsak Akkasilp said on Friday. Twenty-five per cent of available beds are occupied by pneumonia patients, he added.

 

https://www.nationthailand.com/in-focus/40014849

Posted
10 hours ago, anchadian said:

Editoral: As Test and Go goes away, it’s time for our daily Covid-19 reporting to go as well

 

Seems a very bizarre decision by what's supposed to be a news media organization.

 

Do they really think that sticking their heads in the sand and ignoring an issue (or substantially downplaying it) is somehow going to prevent people from continuing to get sick and in some cases die from COVID?  Or that ceasing daily reporting will better remind people to take prudent health precautions?

 

Right now, Thailand's official daily COVID death toll is roughly double that of its official daily road fatalities tally. Are they going to cease reporting on fatal road collisions too, because those clearly are "endemic" to Thailand?  No, I don't think so.

 

  • Like 1
Posted

Update on efforts to develop a new vaccine version better tailored to Omicron and possible future variants:

 

From Johns Hopkins:

 

"Several companies, including Pfizer-BioNTech and Moderna, are developing variant-specific vaccines, but it is unclear how long testing and manufacturing of any newer vaccine versions might take.

 

Moderna this week released preprint data on a bivalent vaccine candidate, mRNA-1273.211, that contains equal mRNA amounts of spike proteins from the ancestral SARS-CoV-2 strain and the Beta variant and could be used as a booster dose. According to the data—which is not yet peer-reviewed—the vaccine produced stronger, longer-lasting antibody responses against SARS-CoV-2 variants, including Omicron, than the company’s original vaccine.

 

Results from a different Moderna bivalent vaccine candidate that uses mRNA from the original virus and Omicron are expected later this spring."

 

https://myemail.constantcontact.com/COVID-19-Updates---April-14--2022.html

 

  • Thanks 1
Posted

News regarding Pfizer's Paxlovid treatment for COVID:

 

WHO backs Pfizer's Paxlovid for certain COVID patients but raises concerns on drug access, pricing

 

"The World Health Organization (WHO) recommended the use of Pfizer's (NYSE:PFE) antiviral pill Paxlovid to treat patients with mild and moderate COVID-19 who are at the highest risk of hospital admission.

 

The WHO suggested not to use the drug in patients at lower risk, as the benefits were found to be negligible, the agency said in an April 22 press release.

 

The WHO called the drug 'best therapeutic choice for high-risk patients to date' but noted that availability, lack of price transparency in bilateral deals made by the producer, and the need for prompt and accurate testing before administering it, are turning the therapy into a major challenge for low- and middle-income countries."

 

(more)

 

https://seekingalpha.com/news/3825662-who-backs-pfizers-paxlovid-in-high-risk-covid-patients-but-raises-concerns-on-drug-access-pricing

 

But...

 

Pfizer COVID-19 pill linked to reports of returning symptoms - Boston Globe

 

Boston Globe highlighted several cases where patients who took the Pfizer’s (NYSE:PFE) COVID-19 pill Paxlovid reported a rebound of symptoms despite testing negative for the virus after the initial infection.

...

In its documents submitted to the FDA seeking regulatory nod for Paxlovid, Pfizer (PFE) noted several cases where trial subjects were found to have a rebound in SARS-CoV-2 RNA levels around Day 10 or Day 14.”

...

Dr. Michael Charness, chief of staff at the VA Boston Healthcare System, ...  concluded that some patients might require a longer course of therapy to develop a stronger immune defense.

 

https://seekingalpha.com/news/3825817-pfizer-covid-19-pill-linked-to-reports-of-returning-symptoms-boston-globe

 

 

  • Thanks 1
Posted

A new study in the U.S. has credited the country's COVID vaccinations program thus far with preventing 2.2 million deaths, 17 million hospitalizations, 66 million COVID infections and $900 billion in health care expenses.

 

Study finds U.S. COVID-19 vaccinations averted 2.2 million deaths

 

(UPI) -- A new study published Friday found COVID-19 vaccinations have prevented 2.2 million deaths in the United States.

 

The Commonwealth Fund study said 17 million hospitalizations were averted by the vaccines between December 12, 2020, and March 31, 2022. More than $899 billion was saved in healthcare costs due to the vaccines, according to the Commonwealth Fund study.

 

The study found there would have been 66 million more COVID-19 infections without the vaccinations.

 

(more)

 

https://www.upi.com/Health_News/2022/04/08/COVID19-commonwelath-fund-study-vaccines-prevented-millions-of-deaths/1421649425164/

 

 

Screenshot_2.jpg.ea52e3e83a7a010e04aa07e87be66c82.jpg

 

https://www.commonwealthfund.org/blog/2022/impact-us-covid-19-vaccination-efforts-march-update

 

"The Commonwealth Fund — among the first private foundations started by a woman philanthropist, Anna M. Harkness — was established in 1918 with the broad charge to enhance the common good.

 

Today, the mission of The Commonwealth Fund is to promote a high-performing health care system that achieves better access, improved quality, and greater efficiency, particularly for society’s most vulnerable, including low-income people, the uninsured, and people of color."

 

  • Thanks 1
Posted

A new report by the CDC has found that COVID remained the third-leading cause of death in the U.S. for the second consecutive year in 2021, trailing only heart disease and cancer, according to provisional mortality data.

 

Provisional Mortality Data — United States, 2021

Early Release / April 22, 2022

 

"For a second year, COVID-19 was the third leading cause of death after heart disease and cancer."

...

In 2021, COVID-19 was listed as the underlying or contributing cause of 460,513 deaths (111.4 per 100,000), an increase from 384,536 deaths (93.2) in 2020 (Table).

...

COVID-19 was the underlying cause for approximately 90% (415,399), and a contributing cause of death for the remaining 10% (45,114) of COVID-19–associated deaths in 2021."

 

 

568529055_Screenshot1.jpg.4a08ad800d1128144ab67edfcac30765.jpg

 

https://www.cdc.gov/mmwr/volumes/71/wr/mm7117e1.htm

 

  • Thanks 1
Guest
This topic is now closed to further replies.
  • Recently Browsing   0 members

    • No registered users viewing this page.



×
×
  • Create New...